Standout Papers

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis 2006 2026 2012 2019 1.1k
  1. Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis (2010)
    Rachel Jones, Jan Willem Cohen Tervaert et al. New England Journal of Medicine
  2. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies (2006)
    Richard Watts, Suzanne Lane et al. Annals of the Rheumatic Diseases
  3. EULAR recommendations for the management of primary small and medium vessel vasculitis (2008)
    Chetan Mukhtyar, Loı̈c Guillevin et al. Annals of the Rheumatic Diseases
  4. EULAR recommendations for the management of large vessel vasculitis (2008)
    Chetan Mukhtyar, Loı̈c Guillevin et al. Annals of the Rheumatic Diseases

Immediate Impact

8 by Nobel laureates 46 from Science/Nature 74 standout
Sub-graph 1 of 20

Citing Papers

Mitochondrial transfer mediates endothelial cell engraftment through mitophagy
2024 StandoutNature
Diagnosis and management of ANCA-associated vasculitis
2024 Standout
41 intermediate papers

Works of Thomas Häuser being referenced

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
2010
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
and 9 more

Author Peers

Author Last Decade Papers Cites
Thomas Häuser 240 3698 1974 1213 83 5.7k
Jeremy Levy 2 1646 896 367 98 3.8k
John E. Tomaszewski 3 3578 1060 429 195 9.1k
Michael N. Koss 2541 1090 435 121 6.5k
Eunhee S. Yi 4821 1393 1214 207 8.7k
Laura Barisoni 812 511 363 107 6.0k
Elizabeth H. Hammond 3 1506 436 330 95 6.6k
Judith Sandbank 3 759 276 339 138 5.3k
Sophie Mavrogeni 1263 712 500 264 4.7k
Jan U. Becker 5 936 233 462 169 4.8k
Christian Rübe 7 3323 480 287 150 6.8k

All Works

Loading papers...

Rankless by CCL
2026